P

Portola Pharmaceuticals

74 employees

Portola Pharmaceuticals develops therapeutics for acute and chronic cardiovascular, and autoimmune and inflammatory diseases.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Therapeutics
Biotechnology / Pharmaceutical
Biopharma
Thrombosis
Oncology

Date founded

2003

Funding rounds raised

Total raised

$125M

from 20 investors over 20 rounds

P

Portola Pharmaceuticals raised $125M on March 4, 2019

Investors: Athyrium Capital Management, LP and HealthCare Royalty Partners

P

Portola Pharmaceuticals raised $89M on November 21, 2011

Investors: - and Temasek

P

Portola Pharmaceuticals raised $45M on October 1, 2011

Investors: Biogen Idec

P

Portola Pharmaceuticals raised $60M on July 1, 2008

Investors: Frazier Healthcare Partners, MPM Capital, Prospect Venture Partners, LP, T. Rowe Price and The D. E. Shaw Group

P

Portola Pharmaceuticals raised $70M on May 7, 2007

Investors: T. Rowe Price, Brookside Capital Inc, Frazier Healthcare Partners and MPM Capital

P

Portola Pharmaceuticals raised $46M on November 8, 2005

Investors: Advanced Technology Ventures, Abingworth, Alta Partners, Frazier Healthcare Partners, MPM Capital and Prospect Venture Partners, LP

FAQ